Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for tumor necrosis factor
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- Transmembrane TNF-α as a Novel Biomarker for the Diagnosis of Cytokine Storms in a Mouse Model of Mu…
- Presence of subclinical inflammation in axial spondyloarthritis patients with NSAID/anti-TNF-α drug-…
- Change in disease activity is associated with TNF-α inhibitor serum levels in patients with axial sp…
- Regulatory Safety Learning Driven by the Mechanism of Action: The Case of TNF-α Inhibitors.
- An Engineered Monovalent Anti-TNF-α Antibody with pH-Sensitive Binding Abrogates Immunogenicity in M…
Most Relevant Clinical Trials
- Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response
- Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthriti…
- The Role of C1q Tumor Necrosis Factor-related Protein 6 in Breast Cancer
- Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors
- Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma …
